FIELD: medicine; ophthalmology.
SUBSTANCE: conjunctival cavity is instilled with 0.3% Ciprofloxacinum solution. Ciprofloxacinum is instilled within 2 days with ten-hour night interval. Thus within the first hour - every 5 minutes, starting from the second hour - every two hours, within the second day - every three hours.
EFFECT: method enables to prevent rough destruction of cornea within all layers by propagative agents within the first day from treatment beginning; to prevent cornea perforation; to provide early infiltrate resorption and cornea ulcer epithelisation and to keep and restore visual functions in a short space of time.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF CENTRAL CORNEAL ULCERS OF BACTERIAL AND HERPETIC ETIOLOGY | 2018 |
|
RU2668713C1 |
| METHOD FOR DETERMINATION OF PRESCRIPTIONS TO CONDUCT COUNTER-HERPETIC THERAPY IN CASE OF CHRONIC CENTRAL BACTERIAL CORNEAL ULCERS | 2016 |
|
RU2623069C1 |
| AGENT FOR TREATMENT OF CONJUNCTIVA INFLAMMATORY DISEASE, BACTERIAL DAMAGE OF RETINA CAPSULE | 2003 |
|
RU2257210C2 |
| METHOD FOR DETERMINING SEVERITY OF CORNEAL ULCER | 2019 |
|
RU2718565C1 |
| AGENT FOR TREATMENT OF TRAUMATIC INFECTIONS OF EYE ANTERIOR PART | 1996 |
|
RU2142288C1 |
| METHOD OF TREATMENT OF PURULENT CORNEAL ULCER | 2015 |
|
RU2602362C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE INFECTIONS P. Aeruginosa CONTAINING RECOMBINANT LYSOZYME | 2011 |
|
RU2548803C2 |
| METHOD OF TREATMENT OF INFLAMMATORY DISEASES OF CORNEA EYE | 2000 |
|
RU2189236C2 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| METHOD FOR TREATING COMPLICATED PURULENT CORNEAL ULCER | 2006 |
|
RU2309710C1 |
